Recent Finacing
Recent Raise
OncoVerity operates a bioinformatics platform integrating single-cell multi‑omics and machine learning to identify resistance drivers, develop therapies (cusatuzumab anti‑CD70) and run AML Phase 2 clinical trials.
Focus Areas
Recent Investors
Funding round
Investors
